A Virtual Living Lab Platform Codeveloped for Mental Health in Youth-Onset Type 2 Diabetes (BrightSpark Care Lab): Protocol for a Mixed Methods Study
JMIR Research Protocols · 2026
DOI: 10.2196/83865 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift JMIR Research Protocols, 2026. Verfasst von Mandy M Archibald und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Mental Health. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes (T2D) is a complex chronic disease that poses significant mental health challenges to affected youth. Despite calls for youth-centered research in this area, qualitative and mixed methods research is lacking, and longitudinal understandings of the mental health experiences of youth have not been generated. Living labs have potential as interactive knowledge exchange and longitudinal research platforms to generate such understandings.
Objective
The proposed research aims to (1) codesign, with youth and parent coresearchers, a virtual living lab platform with an embedded registry of youth with T2D; (2) use this platform to generate longitudinal understandings of youths’ mental health experiences; (3) identify youth priorities for research and care based on the thematic data; and (4) codesign an arts-based knowledge translation (KT) resource to communicate these priorities.
Methods
This study proposes a three-stage longitudinal, qualitatively dominant, convergent mixed methods design. Stage 1 involved codesigning an online platform with youth and parent coresearchers over a 4-month period and establishing a user registry of English-speaking youth (age 10-25 years) with T2D (diagnosed at age 18 years or younger) in Canada and their parents or guardians. In stage 2, up to 50 youth were purposively selected from the registry to complete baseline mental health measures, followed by 12 content modules using diary and arts-based response methods. Inductive thematic and mixed methods analysis will inform stage 3. Up to a third of the stage 3 participants will be purposively selected to identify priorities for mental health research and care and codesign arts-based KT resources to impart critical research findings to stakeholder groups identified with participants and youth coresearchers. This is an experimental modality for data collection, and participant numbers may be fewer; however, methodological insights regarding engagement will be collated and published to support digital strategy in future work.
Results
We recruited 4 youth coresearchers to codesign the BrightSpark online platform—Canada’s first virtual living lab for youth and families with T2D—establishing an embedded registry of youth with T2D and creating the educational content of the 12 modules for the research. Recruitment and data collection began in March 2024 and concluded in September 2025. We anticipate study completion by January 2026.
Conclusions
Youth-onset T2D presents a significant challenge to families and health systems, with less than 30% of youth with T2D achieving treatment targets. Self-management in youth with T2D is further complicated by psychosocial morbidity, identity formation, stigma, blame, shame, historical oppression, and structural barriers to health. This study will contribute a sustainable and novel structure to understand this issue, providing opportunities to generate critically needed understandings of youths’ mental health experiences to advance family-centered research and care. International Registered Report Identifier (IRRID) DERR1-10.2196/83865
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Nursing, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
- Diabetes Research Envisioned and Accomplished in Manitoba, Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
- Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
- Community Representative, Winnipeg, MB, Canada.
- Rady Faculty of Health Sciences, College of Community and Global Health, University of Manitoba, Winnipeg, MB, Canada.
- Partnering for Research Innovations in Mental Health, Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
ORCID-Profile: Mandy M Archibald, Brandy Wicklow, Elizabeth Sellers, Arlene Griffiths, Linda Diffey, Jonathan McGavock, Leslie E Roos, Alexander M Clark, Jennifer Lopez, Josephine Ho, Ernestine Ledoux, Gifty Dzorka, Shahina Parvin, Oluwatoyosi Fagbuyi, Allison Dart
Zitieren
APA
Archibald, M. M., Wicklow, B., Sellers, E., Griffiths, A., Diffey, L., McGavock, J., Roos, L. E., Clark, A. M., Lopez, J., Ho, J., Ledoux, E., Dzorka, G., Parvin, S., Fagbuyi, O., & Dart, A. (2026). A Virtual Living Lab Platform Codeveloped for Mental Health in Youth-Onset Type 2 Diabetes (BrightSpark Care Lab): Protocol for a Mixed Methods Study. JMIR Research Protocols. https://doi.org/10.2196/83865
Vancouver
Archibald MM, Wicklow B, Sellers E, Griffiths A, Diffey L, McGavock J, et al. A Virtual Living Lab Platform Codeveloped for Mental Health in Youth-Onset Type 2 Diabetes (BrightSpark Care Lab): Protocol for a Mixed Methods Study. JMIR Research Protocols. 2026. doi:10.2196/83865
BibTeX
@article{Archibald2026,
author = {Archibald, Mandy M and Wicklow, Brandy and Sellers, Elizabeth and Griffiths, Arlene and Diffey, Linda and McGavock, Jonathan and Roos, Leslie E and Clark, Alexander M and Lopez, Jennifer and Ho, Josephine and Ledoux, Ernestine and Dzorka, Gifty and Parvin, Shahina and Fagbuyi, Oluwatoyosi and Dart, Allison},
title = {A Virtual Living Lab Platform Codeveloped for Mental Health in Youth-Onset Type 2 Diabetes (BrightSpark Care Lab): Protocol for a Mixed Methods Study},
journal = {JMIR Research Protocols},
year = {2026},
doi = {10.2196/83865}
}
EUVIMED